R. Gherardi, M. Coquet, and P. Chérin, Macrophagic myofasciitis lesions assess long-term persistence of vaccine-derived aluminum hydroxide in muscle, Brain, vol.124, pp.1821-1852, 2001.

G. Bassez, F. Authier, and E. Lechapt-zalcman, Inflammatory myopathy with abundant macrophages (IMAM): a condition distinct from macrophagic myofasciitis, sharing similarities with cytophagic histiocytic panniculitis, J Neuropathol Exp Neurol, vol.62, pp.464-74, 2003.

R. Gherardi and F. Authier, Aluminum inclusion macrophagic myofasciitis: a recently identified condition, Immunol Allergy Clin North Am, vol.23, pp.699-712, 2003.

Y. Shoenfeld, N. Agmon-levin, and . Asia, Autoimmune/inflammatory syndrome induced by adjuvants, J Autoimmun, vol.36, pp.4-8, 2011.
DOI : 10.1016/j.jaut.2010.07.003

F. Authier, S. Sauvat, and C. Christov, AlOH3-adjuvanted vaccine-induced macrophagic myofasciitis in rats is influenced by the genetic background, Neuromuscul Disord, vol.16, pp.347-52, 2006.
URL : https://hal.archives-ouvertes.fr/in2p3-00068499

F. Verdier, R. Burnett, C. Michelet-habchi, P. Moretto, F. Fievet-groyne et al., Aluminium assay and evaluation of the local reaction at several time points after intramuscular administration of aluminium containing vaccines in the Cynomolgus monkey, Vaccine, vol.23, pp.1359-1367, 2005.
URL : https://hal.archives-ouvertes.fr/in2p3-00153976

H. Müller, F. Landeghem, P. Schmidt, C. Sommer, and H. Goebel, Macrophagic myofasciitis plus (distinct types of muscular dystrophy), Neuropediatrics, vol.40, pp.174-178

E. Maubec, L. Pinquier, and M. Viguier, Vaccination-induced cutaneous pseudolymphoma, J Am Acad Dermatol, vol.52, pp.623-629, 2005.
DOI : 10.1016/j.jaad.2004.12.021

K. Gruis, J. Teener, and M. Blaivas, Pediatric macrophagic myofasciitis associated with motor delay, Clin Neuropathol, vol.25, issue.4, pp.172-181, 2006.

A. Ryan, N. Bermingham, H. Harrington, and C. Keohane, Atypical presentation of macrophagic myofasciitis 10 years post vaccination, Neuromuscul Disord, vol.16, pp.867-869, 2006.

R. Kalil, A. Monteiro, and M. Lima, Macrophagic myofasciitis in childhood: the role of scanning electron microscopy/energy-dispersive spectroscopy for diagnosis, Ultrastruct Pathol, vol.31, pp.45-50, 2007.

B. Theeler, N. Simper, and J. Ney, Polyglandular autoimmunity with macrophagic myofasciitis, Clin Rheumatol, vol.27, pp.667-669, 2008.

C. Exley, L. Swarbrick, R. Gherardi, and F. Authier, A role for the body burden of aluminium in vaccineassociated macrophagic myofasciitis and chronic fatigue syndrome, Med Hypotheses, vol.72, pp.135-139, 2009.

E. Israeli, N. Agmon-levin, M. Blank, and Y. Shoenfeld, Macrophagic Myofaciitis a Vaccine (alum) Autoimmune-Related Disease, Clin Rev Allergy Immunol, 2010.

J. Pereira, C. Barroso, T. Evangelista, J. Fonseca, and J. Pereira-da-silva, Macrophagic myofasciitis: a case report of autoimmune/inflammatory syndrome induced by adjuvants (ASIA), Acta Reumatol Port, vol.1, pp.75-76, 2011.

P. Chérin, F. Authier, and R. Gherardi, Gallium-67 scintigraphy in macrophagic myofasciitis, Arthritis Rheum, vol.43, pp.1520-1526, 2000.

F. Authier, S. Sauvat, J. Champey, I. Drogou, M. Coquet et al., Chronic fatigue syndrome in patients with macrophagic myofasciitis, Arthritis Rheum, vol.48, pp.569-70, 2003.

M. Couette, M. Boisse, and P. Maison, Long-term persistence of vaccine-derived aluminum hydroxide is associated with chronic cognitive dysfunction, J Inorg Biochem, vol.103, pp.1571-1578, 2009.

S. Rifat, M. Eastwood, D. Mclachlan, and P. Corey, Effect of exposure of miners to aluminium powder, Lancet, vol.336, pp.1162-1165, 1990.

R. Akila, B. Stollery, and V. Riihimaki, Decrements in cognitive performance in metal inert gas welders exposed to aluminum, Occup Environ Med, vol.56, pp.632-639, 1999.

S. Polizzi, E. Pira, and M. Ferrara, Neurotoxic effects of aluminium among foundry workers and Alzheimer's disease, NeuroToxicol, vol.23, pp.761-774, 2002.

F. Authier, C. P. Creange, and A. , Central nervous system disease in patients with macrophagic myofasciitis, Brain, vol.124, pp.974-83, 2001.

D. Simpson, Systemic histiocytosis presenting as macrophagic myofasciitis, J Clin Neuromusc Dis, vol.4, pp.19-22, 2002.

M. Hooper, Myalgic encephalomyelitis : a review with emphasis on key findings in biomedical research

M. Hotopf, A. David, L. Hull, I. Khalida, C. Unwin et al., Role of vaccinations as risk factors for ill health in veterans of the Gulf war: cross sectional study, BMJ, vol.320, pp.1363-1367, 2000.

N. Cherry, F. Creed, and A. Sliman, Health and exposures of United Kingdom Gulf war veterans. Part II: The relation of health to exposure, Occup Environ Med, vol.58, pp.299-306, 2001.

R. Gherardi, Lessons from macrophagic myofasciitis: towards definition of a vaccine adjuvant-related syndrome, Rev Neurol (Paris), vol.159, pp.162-164, 2003.

C. Exley, P. Siesjö, and H. Eriksson, The immunobiology of aluminium adjuvants: how do they really work?, Trends Immunol, vol.31, pp.103-109, 2010.

S. Guis, J. Pellissier, and F. Nicoli, HLA-DRB1*01 and macrophagic myofasciitis, Arthritis Rheum, vol.46, pp.2535-2537, 2002.
DOI : 10.1002/art.10465
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2833637

S. 31-van-rensburg, F. Potocnik, and T. Kiss, Serum concentrations of some metals and steroids in patients with chronic fatigue syndrome with reference to neurological and cognitive abnormalities, Brain Res Bull, vol.55, pp.319-344, 2001.

C. Exley, G. Mamutse, and O. Korchazhkina, Elevated urinary excretion of aluminium and iron in multiple sclerosis, Multiple Sclerosis, vol.12, pp.533-540, 2006.

C. Shaw and M. Petrik, Aluminum hydroxide injections lead to motor deficits and motor neuron degeneration, J. Inorg. Biochem, vol.103, pp.1555-1562, 2009.

L. Tomljenovic and C. Shaw, Aluminum Vaccine Adjuvants: Are they Safe, Curr Med Chem, vol.18, pp.2630-2637, 2011.
DOI : 10.2174/092986711795933740

R. Flarend, S. Hem, and J. White, In vivo absorption of aluminium-containing vaccine adjuvants using 26 Al, Vaccine, vol.15, pp.1314-1318, 1997.

G. Morefield, A. Sokolovska, D. Jiang, H. Hogenesch, J. Robinson et al., Role of aluminumcontaining adjuvants in antigen internalization by dendritic cells in vitro, Vaccine, vol.23, pp.1588-1595, 2005.

J. Hamilton, R. Byrne, and G. Whitty, Particulate adjuvants can induce macrophage survival, DNA synthesis, and a synergistic proliferative response to GM-CSF and CSF-1, J Leukoc Biol, vol.67, pp.226-232, 2000.

M. Brigitte, C. Schilte, and A. Plonquet, Muscle resident macrophages control the immune cell reaction in a mouse model of notexin-induced myoinjury, Arthritis Rheum, vol.62, pp.268-279, 2010.
URL : https://hal.archives-ouvertes.fr/pasteur-01402283

Z. Khan, C. Christov, and F. Lux, Bio-distribution of nanosized aluminic particles after i.m. injection in the mouse, Communication to the Nanotoxicology Meeting, 2010.

Z. Khan, O. Tillement, J. Cadusseau, and R. Gherardi, Nanoparticle neurodelivery depends on a MCP-1- driven Trojan horse mechanism, 2011.